Back
Intellia Therapeutics Stock Price Chart
Sponsored
Make The SMART Move and Get The Inflation Survival Plan!
So don't wait until it's too late, act now and secure your future TODAY!
Sell
31
NTLA
Intellia Therapeutics
Last Price:
38.29
Seasonality Move:
10.02%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Get Instant Access To Today's Top Options List!
View this list for FREE now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39 | Sell |
| 20-day SMA: | 39.58 | Sell |
| 50-day SMA: | 39.7 | Sell |
| 200-day SMA: | 49.82 | Sell |
| 8-day EMA: | 38.53 | Sell |
| 20-day EMA: | 39.18 | Sell |
| 50-day EMA: | 39.99 | Sell |
| 200-day EMA: | 50.32 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 46.91 | Sell |
| Chaikin Money Flow: | 685838 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.59 - 41.23) | Sell |
| Bollinger Bands (100): | (36.05 - 47.05) | Sell |
Intellia Therapeutics Technical Analysis
| Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 38.30 while NTLA 8-day simple moving average is 39.00, which is a Sell signal.
- The stock price of NTLA is 38.30 while Intellia Therapeutics 20-day SMA is 39.58, which makes it a Sell.
- Intellia Therapeutics 50-day simple moving average is 39.70 while NTLA share price is 38.30, making it a Sell technically.
- NTLA stock price is 38.30 and Intellia Therapeutics 200-day simple moving average is 49.82, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
31
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $38.30. The Score for NTLA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
3.37B
Price in USD:
38.30
Share Volume:
764.67K
Intellia Therapeutics 52-Week Range
52-Week High:
78.58
52-Week Low:
32.44
Sell
31
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 38.30 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 38.30 while NTLA 8-day exponential moving average is 38.53, which is a Sell signal.
- The stock price of NTLA is 38.30 while Intellia Therapeutics 20-day EMA is 39.18, which makes it a Sell.
- Intellia Therapeutics 50-day exponential moving average is 39.99 while NTLA share price is 38.30, making it a Sell technically.
- NTLA stock price is 38.30 and Intellia Therapeutics 200-day simple moving average is 50.32, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is -0.53, suggesting Intellia Therapeutics is a Sell
- Intellia Therapeutics Relative Strength Index (RSI) is 46.91, which suggest Intellia Therapeutics is oversold
- The Bollinger Bands (25) for Intellia Therapeutics is (37.59 - 41.23), which suggest Intellia Therapeutics is a Sell
- The Bollinger Bands (100) for Intellia Therapeutics is (36.05 - 47.05), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.